MedTrace Logo

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

NCT00050895 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 775

Last updated 2021-11-01

No results posted yet for this study

Summary

With new strategies and drugs available, many different regimens exist for the treatment of HIV. The purpose of this study is to compare three different anti-HIV drug regimens as first-time treatments for HIV infection.

Conditions

  • HIV Infections

Interventions

DRUG

Lopinavir/ritonavir

DRUG

Efavirenz

DRUG

Stavudine

DRUG

Zidovudine

DRUG

Lamivudine

DRUG

Tenofovir disoproxil fumarate

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Sharon Riddler, MD · University of Pittsburgh

  • Richard Haubrich, MD · University of California, San Diego, Division of Infectious Diseases

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2006-03-31

Countries

  • United States
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00050895 on ClinicalTrials.gov